National Cancer Institute "Cancer Moonshot Biobank"
NCT04314401 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 1600
Last updated 2026-05-13
Summary
This trial collects multiple tissue and blood samples, along with medical information, from cancer patients. The "Cancer Moonshot Biobank" is a longitudinal study. This means it collects and stores samples and information over time, throughout the course of a patient's cancer treatment. By looking at samples and information collected from the same people over time, researchers hope to better understand how cancer changes over time and over the course of medical treatments.
Conditions
- Acute Myeloid Leukemia
- Anatomic Stage III Breast Cancer AJCC v8
- Anatomic Stage IV Breast Cancer AJCC v8
- Clinical Stage IV Esophageal Adenocarcinoma AJCC v8
- Clinical Stage IV Gastric Cancer AJCC v8
- Clinical Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8
- Esophageal Carcinoma
- Fallopian Tube Carcinoma
- Gastric Carcinoma
- Hormone Receptor-Positive Breast Carcinoma
- Invasive Breast Carcinoma
- Lung Non-Small Cell Carcinoma
- Lung Small Cell Carcinoma
- Malignant Solid Neoplasm
- Melanoma
- Metastatic Prostate Carcinoma
- Multiple Myeloma
- Ovarian Carcinoma
- Ovarian High Grade Serous Adenocarcinoma
- Primary Peritoneal Carcinoma
- Stage III Fallopian Tube Cancer AJCC v8
- Stage III Lung Cancer AJCC v8
- Stage III Ovarian Cancer AJCC v8
- Stage IV Colorectal Cancer AJCC v8
- Stage IV Fallopian Tube Cancer AJCC v8
- Stage IV Lung Cancer AJCC v8
- Stage IV Ovarian Cancer AJCC v8
- Stage IVB Prostate Cancer AJCC v8
- Triple-Negative Breast Carcinoma
Interventions
- PROCEDURE
-
Biospecimen Collection
Undergo collection of blood, tissue, bone marrow, and cerebral spinal fluid samples
- PROCEDURE
-
Computed Tomography
Undergo CT
- PROCEDURE
-
Magnetic Resonance Imaging
Undergo MRI
- OTHER
-
Medical Chart Review
Medical charts are reviewed and data is collected
- PROCEDURE
-
Paracentesis
Undergo paracentesis
- PROCEDURE
-
Positron Emission Tomography
Undergo PET/CT
Sponsors & Collaborators
-
National Cancer Institute (NCI)
lead NIH
Principal Investigators
-
Lyndsay N Harris · National Cancer Institute (NCI)
Eligibility
- Min Age
- 13 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-11-11
- Primary Completion
- 2027-04-30
- Completion
- 2027-04-30
Countries
- United States
- Puerto Rico
Study Locations
More Related Trials
-
Collection of Blood From Patients With Cancer
NCT00034216 ·Status: RECRUITING
-
Biospecimen Procurement for Center for Immuno-Oncology Immunotherapy Protocols
NCT02682667 ·Status: RECRUITING
-
Utilization of the OncoCEE™ Platform to Evaluate Selected Biomarker Alterations in CTCs Isolated From Patients With MBC
NCT02436772 ·Status: COMPLETED
-
Biobank and Register of Patients With Agresive Tumors for Translational and Analytical Research
NCT05539677 ·Status: RECRUITING
-
PRospective REgistry of Advanced Stage CancER (PREFER) Patients to Assess Prevalence of Actionable Biomarkers and Driver Mutations to Address Disparities in Precision Medicine
NCT05697198 ·Status: COMPLETED
-
Defining the Clinical Potential of Mass Response As a Biomarker for Patient Tumor Sensitivity to Drugs
NCT04985357 ·Status: WITHDRAWN
-
Analysis of Whole Body Magnetic Resonance Imaging and Liquid Biopsy for Early Detection of Cancer in Patients With a Strong Family History of Cancer
NCT05868486 ·Status: ACTIVE_NOT_RECRUITING ·Phase: EARLY_PHASE1
-
Prospective Procurement of Tumor Tissue to Identify Novel Therapeutic Targets and Study the Tumor Microenvironment
NCT05600933 ·Status: ENROLLING_BY_INVITATION
-
Study of Specimens From Young Patients With Neuroblastoma
NCT00958659 ·Status: COMPLETED
-
Collection of Blood, Bone Marrow, Tumor or Tissue Samples
NCT00043615 ·Status: COMPLETED
-
Biomarkers in Tumor Tissue Samples From Patients With Newly Diagnosed Neuroblastoma or Ganglioneuroblastoma
NCT00904241 ·Status: ACTIVE_NOT_RECRUITING
-
Studying Biomarkers in Samples From Patients With Rhabdomyosarcoma
NCT01433237 ·Status: COMPLETED
-
Biomarkers of Angiogenesis and Disease in Patients With Unresectable Malignant Mesothelioma Treated on Clinical Trial CALGB-30107
NCT00898547 ·Status: TERMINATED
-
Comprehensive Genomic Analysis in Tissue Samples From Patients With Recurrent or Stage IV Non-small Cell Lung Cancer
NCT02178163 ·Status: RECRUITING ·Phase: NA
-
Collecting Blood and Tissue Samples From Family Members of Patients With Pancreatic Diseases, Pancreatic Cancer, and Melanoma
NCT00835133 ·Status: ACTIVE_NOT_RECRUITING
-
Study of Blood and Tissue Samples From Patients With Aggressive Non-Hodgkin B-Cell Lymphoma or Hodgkin Lymphoma
NCT00981097 ·Status: COMPLETED
-
Genomic Sequencing in Determining Treatment in Patients With Metastatic Cancer or Cancer That Cannot Be Removed by Surgery
NCT02566421 ·Status: TERMINATED ·Phase: NA
-
Collecting and Storing Blood Samples From Patients With Cancer
NCT00900120 ·Status: WITHDRAWN
-
Immunophenotyping in Metastatic Kidney Cancer Patients Receiving Ablative Therapy
NCT05112627 ·Status: COMPLETED
-
Disease Burden and Biology Using Tumor Cell Free DNA in Metastatic Kidney Cancer
NCT04883827 ·Status: COMPLETED
-
Specimen Collection from Patients with Non-Hematologic Cancer for Use in Development of a Liquid Biopsy Assay
NCT02586389 ·Status: RECRUITING
-
Collection of Serum and Tissue Samples From Patients With Biopsy-Proved or Suspected Malignant Disease
NCT00026884 ·Status: RECRUITING
-
Collecting Tissue Samples From Patients With Leukemia or Other Blood Disorders Planning to Enroll in an ECOG Leukemia Treatment Clinical Trial
NCT00897767 ·Status: COMPLETED
-
S9704-S0014-S0313A Studying Genes in Samples From Patients With Limited or Advanced Diffuse Large B-Cell Lymphoma
NCT01563861 ·Status: COMPLETED
-
Collection of Tissue Blocks or Slides From Patients With Cancer
NCT02810405 ·Status: COMPLETED